---
AWKN-002
About
AWKN-P002 - a novel psychedelic MAT consisting of a patent pending proprietary S-Ketamine formulation, administered sub-lingually via an oral thin film (OTF), used in combination with manualized relapse prevention CBT to treat AUD in the US.
Status:
Goals:
IP:
Sign Up for Newsletter
MAIN OFFICE
Awakn Life Sciences Corp.
301-217 Queen St. W
Toronto, Ontario M5V 0R2
Canada
© 2023 Awakn Life Sciences Corp | Privacy Policy | Disclaimer